MECLIZINE HYDROCHLORIDE
Generic: MECLIZINE
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.Manufacturer
ORALRoute
MECLIZINE HYDROCHLORIDEActive Substance
2019-02-22Original Approval
MECLIZINE HYDROCHLORIDE is FDA application ANDA205136, sponsored by HERITAGE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2026-03-16
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NFailed tablet specifications.
Class II2022-04-13
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per cartoncGMP deviations: Temperature abuse
Top Reported Reactions
1
DIZZINESS
1,667 reports
2
NAUSEA
1,440 reports
3
FATIGUE
1,400 reports
4
HEADACHE
1,080 reports
5
DIARRHOEA
1,069 reports
6
PAIN
1,023 reports
7
FALL
1,011 reports
8
DYSPNOEA
894 reports
9
CHRONIC KIDNEY DISEASE
842 reports
10
ASTHENIA
834 reports